Therapeutics: Death-associated protein kinase 1 (DAPK1; DAPK)

In vitro and mouse studies suggest inhibiting DAPK1 could help treat p53-mutant, triple-negative breast cancer (TNBC). In p53-mutant TNBC cell lines, DAPK1 shRNA or a DAPK1 inhibitor decreased growth ...